Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Valmet to rebuild Metsä Tissue's tissue machines in Raubach in Germany and Pauliström in Sweden

Valmet Oyj's press release on September 20, 2016 at 11:00 a.m. EET Metsä Tissue has selected Valmet as supplier for the upgrades of tissue machine TM3 in Raubach, Germany and the tissue machine in Pauliström, Sweden. The orders were included in Valmet's second quarter 2016, orders received. The value of the orders will not be disclosed. Earlier this year Metsä Tissue started up its tissue machine TM1 in Raubach, Germany after Valmet's extensive rebuild of the wet section, where a new OptiFlo II TIS headbox and an Advantage ViscoNip press were installed. The target of this rebuild

SimCorp A/S – Share buyback program

On 10 May 2016 SimCorp A/S announced a share buyback program in compliance with the provisions of Commission Regulation No. 2273/2003 of 22 December 2003, also referred to as the “Safe Harbour”. As of 3 July 2016 the program is carried out in compliance with the provisions of Regulation No. 596/2014 of the European Parliament and of the Council on market abuse (the Market Abuse Regulation - MAR) and delegated legislation under MAR. In connection with the program SimCorp A/S will repurchase shares for an amount of up to EUR 40.0m (approx. DKK 297.6m) in the period from 10 May 2016 to 20

Status up-date and planned rights issue

Hoersholm, Denmark September 20th 2016 – Oncology Venture Sweden AB:s (OV:ST) daughter company Oncology Venture ApS announces the entering of a co-development agreement with Cadila Pharmaceuticals Ltd. (“Cadila”) to advance the anticancer product LiPlaCis® in combination with its Drug Response Predictor – DRP™. The aim is to evaluate the LiPlaCis efficacy in several different indications and perform a randomized phase 3 trial as corner stone and part of the data package study for marketing approval by the FDA, EMA, CDSCO (Central Drugs Standard Control Organization of India). Cadila will

Oncology Venture enters development deal with Cadila Pharmaceuticals on LiPlaCis® and its Drug Response Predictor

Hoersholm, Denmark, September 20th, 2016 – Oncology Venture Sweden AB (OV:ST) and Cadila Pharmaceuticals Ltd., Ahmedabad, State of Gujarat, India today announce the entering of a co-development agreement to develop the anticancer product LiPlaCis® in combination with its Drug Response Predictor – DRP™. The aim is to evaluate the LiPlaCis efficacy in several different indications and perform a randomized phase 3 trial as corner stone and part of the data package study for marketing approval by the FDA, EMA, CDSCO (Central Drugs Standard Control Organization of India). The mutual goal is to

Myntkartan.se helps Swedes empty their piggybanks of coins worth SEK 2.6 billion

After 30 June 2017, all of the current coins, with the exception of the 10-krona, will become invalid. To make it easier for people to use their old coins, we are launching myntkartan.se, a map that helps you find the nearest point where you can hand over your coins.On 3 October, the new 1, 2 and 5-krona coins will be released, replacing the current ones. The 10-krona coin will remain unchanged. At the same time, work will begin on gathering in the almost SEK 2.6 billion worth of coins that become invalid after 30 June 2017. On average, each Swedish household has SEK 779 in coins, most of

Yggdrasil Gaming signs deal with Casumo

Yggdrasil Gaming , Cherry’s game development Business Area, has signed a deal with Casumo to provide access to its entire award-winning casino product suite including its built-in promotional tools.Fredrik Elmqvist, CEO at Yggdrasil Gaming, said: “Casumo are one of the most creative, experienced and advanced online casinos in the world. We love working with operators that provide us with constant creative challenges – it keeps us on our toes, motivated and competitive. Casumo’s passion for gamification and customer engagement is shared by Yggdrasil and I’m

Tieto appoints Alexandra Drevenlid as Chief Digital Officer

Alexandra Drevenlid has been appointed Chief Digital Officer to further enhance the digital experience of Tieto. Drevenlid will focus on driving digitalization both for customers and internally, supporting Tieto’s strategic aim to be customers’ first choice for business renewal.Alexandra Drevenlid joins Tieto from Tele2, where she has held several leadership roles during the past decade, most currently as Director Network & IT and Chief Technology and Information Officer. Prior to her long career at Tele2, Drevenlid was Director of Marketing at Dynarc Ab and Head of Engineering at GlobalOne

YIT awarded a BREEAM certificate in Russia

YIT CORPORATION News, September 20, 2016 at 10:00 a.m.YIT’s residential building in Russia has been awarded the BREEAM certificate. The building is part of the Sovremennik residential development in Kazan. According to the certification criteria, the building has an excellent balance between energy efficiency and comfort of living, thanks to several different factors: · the use of occupancy detectors and daylight sensors to automate the lighting of corridors and staircases, along with energy-efficient lights · energy-efficient outdoor lighting · efficient building services

Itiviti wins Technology Innovator Award by CV Magazine

Stockholm, Sweden, September 20, 2016 – Itiviti, world-leading technology provider for the capital markets industry, has been named a winner of the 2016 Technology Innovator Awards, presented by Corporate Vision (CV) Magazine. Tbricks by Itiviti was recognized as Best Electronic Trading Technology Solutions & Most Innovative Trading Platform.Corporate Vision is dedicated to working around the clock to shine a spotlight on the brightest, best performing and most deserving companies and individuals from around the business world. The 2016 Technology Innovator Awards were designed to recognize

Farstad Shipping ASA – Concentrates its activities in Australia

Farstad Shipping concentrates its oil service activity in Australia to Perth and will close down the management office in Melbourne. Consequently, the Australian onshore organization will be reduced from 65 to around 30 employees. - Farstad Shipping has participated in the development of the offshore oil and gas industry in Australia since the 1990s, and has become one of the leading oil service companies in the region. To secure this position also in the future, we are now transferring all of our activities to Perth, making it our new headquarters in Australia, says Karl-Johan Bakken,

HiQ NOMINATED IN SWEDISH PUBLISHING AWARDS WITH THE MUNICIPALITY OF KUNGÄLV

HiQ has delivered many successful projects within digital communication. One of these, the new kungalv.se  for the municipality of Kungälv, is now nominated in the Swedish Publishing Awards in the ”Public sector web sites” category.“We’re very happy! One of the goals was to be ground-breaking in terms of design for municipality web sites, and create something completely new and more user-friendly, simplifying for everyone who live and work in Kungälv. A site that inspires, builds pride, and that is not a colossus of information. This nomination shows us that we,

Selvaag Bolig ASA: Purchase of treasury shares

Selvaag Bolig ASA purchased 13 030 treasury shares on 19 September 2016. The shares were purchased at an average price of NOK 40.00. The shares were purchased for the company's share programmes for employees. After the transaction, Selvaag Bolig owns 497 436 treasury shares. Further information fromSverre Molvik, CFO, Selvaag Bolig ASATelephone: +47 401 00 585, e-mail: smo@selvaagbolig.no Selvaag Bolig ASA is a residential property developer controlling the entire value chain from acquisition of land to sale of homes. The company has several thousand homes under development at

Industrifonden strengthens its Life Science team

Industrifonden strengthens its Life Science investment team by recruiting Patrik Sobocki as Investment Manager. Patrik has extensive experience from the pharmaceutical industry, academic research and developing startup companies.Before joining Industrifonden, Patrik Sobocki held the position of European Chief Operating Officer for the business area Real World Evidence at IMS Health, the world’s leading provider of information and technology services to the healthcare industry. The role included responsibility for IMS Health’s M&A strategy within Real World Evidence. At Industrifonden,

Akastor ASA: Akastor and Mitsui create joint venture

Akastor ASA (OSE: AKA), an oil service investment company, announced today that it has signed a Heads of Agreement with MITSUI & CO., LTD, a leading Japanese trading and investment company, and its Japanese partner ("Mitsui"), to create a joint venture with 50/50 ownership between AKOFS Offshore AS ("AKOFS") and Mitsui. The joint venture will acquire both the Skandi Santos hull from DOF Subsea Rederi AS and the Skandi Santos topside from AKOFS. The joint venture will subsequently enter into a lease agreement with AKOFS corresponding to the remaining contract duration between AKOFS and

DOF SUBSEA REDERI AS - SALE OF SKANDI SANTOS.

AKASTOR ASA (AKA) has today published a press release containing information on the establishment of a joint venture under establishment between AKA and other interests which, inter alia, will acquire the vessel SKANDI SANTOS (the “Vessel”) by agreement with DOF Subsea Rederi AS. The sale releases approx. NOK 350 mill in liquidity after coverage of all costs and repayment of debt. DOF Subsea Rederi AS has been the Vessel’s registered owner since its delivery in 2009. The Vessel has since then served under a bareboat charter contract with AKOFS, a company in the AKASTOR Group.

Stem cell researcher from Lund University receives the Fernström Prize

Is it possible to convert a patient’s own skin cells into functioning nerve cells? Or insert healthy genes to reprogram the cells of a damaged brain? Stem cell researcher Malin Parmar at Lund University in Sweden is studying these types of issues, in close collaboration with clinical researchers. She is now awarded a prize of SEK 100 000 from the Eric K. Fernström Foundation for her work.Every year, the Fernström Foundation presents one large Nordic prize (which will be announced later in September) as well as local prizes to researchers at the six faculties of medicine in Sweden. Malin

Change to Eltel’s Group Management Team - Henrik Sundell appointed as General Counsel

Henrik Sundell has been appointed as General Counsel and a member of the Group Management Team at Eltel as of 1 October 2016. Henrik Sundell will report to Eltel’s President and CEO Håkan Kirstein. Prior to joining Eltel, Henrik Sundell has served in similar senior positions in various international companies, among others AGA, Ericsson, DeLaval, and most recently, Fingerprint Cards. For further information:Ingela UlfvesVP – Investor Relations and Group CommunicationsTel: +358 40 311 3009, ingela.ulfves@eltelnetworks.com  About EltelEltel is a leading European provider of

BioArctic enters into Collaboration with AbbVie for Parkinson’s Disease Research

Stockholm, Sweden, September 20, 2016 – BioArctic announced that it entered into a strategically important collaboration with AbbVie (NYSE: ABBV), a global biopharmaceutical company, to develop and commercialize BioArctic’s portfolio of antibodies directed against alpha-synuclein for the treatment of Parkinson’s disease and other potential indications. Parkinson’s disease is the second most-common neurological disease, affecting more than 10 million people worldwide. Mutations in alpha-synuclein are strongly linked to development of Parkinson’s disease. Soluble aggregates of the alpha-

Cantargia prepares intensified development strategy and capital raising

· Expands its initial clinical phase I/IIa study of CAN04 with combination therapies · Makes additional investments in the production process of CAN04 · Initiates a project to develop a new antibody within the IL1RAP platform Cantargia AB today announced that the board has taken a decision on an enhanced development strategy for the company and its product candidate CAN04, and is initiating a project around a new antibody for the treatment of autoimmune and inflammatory diseases. To accomplish this, the company plans to conduct a capital raising of approximately MSEK 80, in addition

Cloetta completes early redemption of its Bonds

As indicated in its press release of 17 August 2016, Cloetta AB (publ) completed the early redemption of its outstanding SEK1,000 million Senior Secured Notes (the “Bonds”) on 19 September 2016, as part of the previously communicated overall refinancing of its existing debt financing.The new financing structure will secure Cloetta’s ability to pay dividends in the future and will at the same time provide financial flexibility for potential complementary acquisitions. In July, 2016, Cloetta entered into a new term and revolving facilities agreement with a group of four banks, amounting in

Transition and change for increased competitiveness and long-term profitability

Within the context of Södra's Group strategy, investments and restructuring are now being realised to increase competitiveness and long-term profitability. The results for 2016 will be impacted, and operating profit for the first eight months of the year totalled SEK 553 million (1,660). "Operating profit is in line with expectations, due to lower prices for market pulp and sawn timber, our transition and the change programme," said Södra's CEO Lars Idermark.Net sales rose slightly to SEK 12,268 million (12,186), while operating profit declined to SEK 553 million compared with an

PRESS RELEASE: ChromoGenics showcases the dynamic glass at Glasstec 2016.

ConverLight™ Dynamic Glass enables designers to use more glass while still meeting the performance objectives of building energy codes and standards. ChromoGenics is showcasing the dynamic glass ConverLight™ at the Glasstec exhibition in Germany September 20-23.“We are delighted to present the smart glass ConverLight™ at the trade show in Düsseldorf,” says Thomas Almesjö, CEO at ChromoGenics. “There is a great interest for advanced materials that support sustainable buildings. Our dynamic glass enables freedom in design for creative architects and in building projects.”

Ferronordic Machines to become distributor of Rottne Industri AB

Press Release Stockholm, 20 September 2016Ferronordic Machines has entered into an agreement with Rottne Industri AB under which the company will become the official distributor for Rottne forestry equipment in all of Russia. Rottne was founded in 1955 and is one of the pioneers in the mechanization of the modern forest industry. The product range includes a complete program of both forwarders and harvesters. As part of the cooperation with Ferronordic Machines, Rottne will develop a new series of forwarders and harvesters for the Russian market. All machines will be equipped with

Installation initiated for Elekta’s high-field MR-adaptive linear accelerator at Froedtert & the Medical College of Wisconsin Clinical Cancer Center

New clinical research program will focus on advanced image-guided radiotherapy for cancer patientsMILWAUKEE, September 20, 2016 – Elekta (EKTA-B.ST), its MRI technology partner Royal Philips (NYSE: PHG, AEX: PHIA) and the Froedtert & the Medical College of Wisconsin Cancer Network recently began installation of an investigational high-field MR-adaptive linear accelerator (MR-linac) system at the Froedtert & MCW Clinical Cancer Center at Froedtert Hospital, eastern Wisconsin’s only academic medical center. The Clinical Cancer Center, part of the Froedtert & MCW Cancer Network, is the

There are no items matching the current filter
There are no more items matching the current filter
Back to top